CORRECTION article

Front. Oncol., 19 May 2022

Sec. Cancer Molecular Targets and Therapeutics

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.917378

RETRACTED: Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation

A retraction of this article was approved in:

  1. Retraction: Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation

    1. Read retraction
Hongbo Qu*Hongbo Qu1*Fang ZhuFang Zhu2Huaying DongHuaying Dong3Xiongqiang HuXiongqiang Hu1Mingli HanMingli Han4
  • 1Department of Breast and Thyroid Surgery, The First People’s Hospital of Chenzhou, Chenzhou, China
  • 2Department of Breast Health Center, The First People’s Hospital of Chenzhou (South Hospital), Chenzhou, China
  • 3Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou, China
  • 4Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Qu H, Zhu F, Dong H, Hu X and Han M (2022) Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation. Front. Oncol. 12:917378. doi: 10.3389/fonc.2022.917378

Received: 12 April 2022; Accepted: 19 April 2022;
Published: 19 May 2022; Retracted: 04 March 2025.

Edited and reviewed by:

Marie R. Webster, Lankenau Institute for Medical Research, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.